Featured Article
Better cardiovascular risk models for women have been developed using a large dataset of more than 20,000 participants in the UK Biobank.
Precision Oncology Today
Magazine
Beginning a New Era of Precision Alzheimer’s Therapeutics
Alzheimer’s is a disease associated with aging and impacts almost seven million people in the U.S. over the age of 65, with women and Black or Hispanic populations disproportionately affected by the condition. Finding an effective treatment for Alzheimer’s disease has proved to be a long and difficult quest.
5 Startups With Proteomics Potential Attracting Investor Cash
Investor appetite is growing for startups that can make proteomics faster, cheaper, and more informative for use in precision medicine. Here are five proteomics...
Trending on Inside Precision Medicine
Walgreens Dives into Gene and Cell Therapy Delivery
Gene and cell therapies will now be offered through Walgreens' new specialty pharmacy.
A Newly Discovered Tumor Mechanism Could Improve Immunotherapies
Researchers have discovered how tumor cells can stop a T-cell-mediated immune response; a finding that could make immunotherapies more effective.
Annual Multi-Omics Test Spots Pancreatic Cancer
A simplified multi-omics test that involves just one blood sample per year can spot early pancreatic cancer and could empower patients to take a more active role in their health, researchers report.